{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:25:33Z","timestamp":1761675933602},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10689-012-9518-6","type":"journal-article","created":{"date-parts":[[2012,3,4]],"date-time":"2012-03-04T15:56:31Z","timestamp":1330876591000},"page":"343-349","source":"Crossref","is-referenced-by-count":14,"title":["Adequacy of family history taking in ovarian cancer patients: a population-based study"],"prefix":"10.1007","volume":"11","author":[{"given":"Anne M.","family":"van Altena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"van Aarle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambertus A. L. M.","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon F. A. G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,3]]},"reference":[{"issue":"5","key":"9518_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.1998.tb10148.x","volume":"105","author":"JF Stratton","year":"1998","unstructured":"Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA (1998) A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105(5):493\u2013499","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"9518_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","volume":"3","author":"HT Lynch","year":"2009","unstructured":"Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M et al (2009) Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Mol Oncol 3(2):97\u2013137. doi: 10.1016\/j.molonc.2009.02.004","journal-title":"Mol Oncol"},{"issue":"4","key":"9518_CR3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","volume":"178","author":"SC Rubin","year":"1998","unstructured":"Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR et al (1998) BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol 178(4):670\u2013677","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"9518_CR4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","volume":"104","author":"T Pal","year":"2005","unstructured":"Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104(12):2807\u20132816. doi: 10.1002\/cncr.21536","journal-title":"Cancer"},{"issue":"3","key":"9518_CR5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68(3):700\u2013710","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9518_CR6","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.ygyno.2011.01.020","volume":"121","author":"S Zhang","year":"2011","unstructured":"Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA et al (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121(2):2919\u20132921. doi: 10.1016\/j.ygyno.2011.01.020","journal-title":"Gynecol Oncol"},{"issue":"5","key":"9518_CR7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"9518_CR8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646. doi: 10.1126\/science.1088759","journal-title":"Science"},{"issue":"2","key":"9518_CR9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","volume":"3","author":"SJ Ramus","year":"2009","unstructured":"Ramus SJ, Gayther SA (2009) The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol Oncol 3(2):138\u2013150. doi: 10.1016\/j.molonc.2009.02.001","journal-title":"Mol Oncol"},{"issue":"22","key":"9518_CR10","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C et al (2011) Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305(22):2295\u20132303. doi: 10.1001\/jama.2011.766","journal-title":"JAMA"},{"issue":"12","key":"9518_CR11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1471-0528.2007.01499.x","volume":"114","author":"ER Woodward","year":"2007","unstructured":"Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG (2007) Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG 114(12):1500\u20131509. doi: 10.1111\/j.1471-0528.2007.01499.x","journal-title":"BJOG"},{"issue":"2","key":"9518_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","volume":"296","author":"A Finch","year":"2006","unstructured":"Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296(2):185\u2013192. doi: 10.1001\/jama.296.2.185","journal-title":"JAMA"},{"issue":"21","key":"9518_CR13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615. doi: 10.1056\/NEJMoa020119","journal-title":"N Engl J Med"},{"issue":"21","key":"9518_CR14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616\u20131622. doi: 10.1056\/NEJMoa012158","journal-title":"N Engl J Med"},{"issue":"3","key":"9518_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijc.20429","volume":"112","author":"R Calderon-Margalit","year":"2004","unstructured":"Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer 112(3):357\u2013364. doi: 10.1002\/ijc.20429","journal-title":"Int J Cancer"},{"key":"9518_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.publhealth.012809.103621","volume":"31","author":"R Valdez","year":"2010","unstructured":"Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ (2010) Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health 31:69\u201387. doi: 10.1146\/annurev.publhealth.012809.103621","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"9518_CR17","first-page":"239","volume":"27","author":"HJ Murff","year":"2004","unstructured":"Murff HJ, Byrne D, Syngal S (2004) Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 27(3):239\u2013245. doi: 10.1016\/j.amepre.2004.05.003","journal-title":"Am J Prev Med"},{"issue":"5","key":"9518_CR18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1463-1318.2009.01898.x","volume":"11","author":"W Foo","year":"2009","unstructured":"Foo W, Young JM, Solomon MJ, Wright CM (2009) Family history? The forgotten question in high-risk colorectal cancer patients. Color Dis 11(5):450\u2013455. doi: 10.1111\/j.1463-1318.2009.01898.x","journal-title":"Color Dis"},{"issue":"5","key":"9518_CR19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1463-1318.2009.01830.x","volume":"11","author":"G Trano","year":"2009","unstructured":"Trano G, Wasmuth HH, Sjursen W, Hofsli E, Vatten LJ (2009) Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study. Color Dis 11(5):456\u2013461. doi: 10.1111\/j.1463-1318.2009.01830.x","journal-title":"Color Dis"},{"issue":"1","key":"9518_CR20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10689-006-9114-8","volume":"6","author":"DA Dijk van","year":"2007","unstructured":"van Dijk DA, Oostindier MJ, Kloosterman-Boele WM, Krijnen P, Vasen HF (2007) Family history is neglected in the work-up of patients with colorectal cancer: a quality assessment using cancer registry data. Fam Cancer 6(1):131\u2013134. doi: 10.1007\/s10689-006-9114-8","journal-title":"Fam Cancer"},{"issue":"2","key":"9518_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0749-3797(02)00593-7","volume":"24","author":"A Ziogas","year":"2003","unstructured":"Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24(2):190\u2013198. doi: 10.1016\/S0749-3797(02)00593-7","journal-title":"Am J Prev Med"},{"issue":"12","key":"9518_CR22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.292.12.1480","volume":"292","author":"HJ Murff","year":"2004","unstructured":"Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292(12):1480\u20131489","journal-title":"JAMA"},{"issue":"4","key":"9518_CR23","first-page":"309","volume":"36","author":"FS Douglas","year":"1999","unstructured":"Douglas FS, O\u2019Dair LC, Robinson M, Evans DG, Lynch SA (1999) The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet 36(4):309\u2013312. doi: 10.1136\/jmg.36.4.309","journal-title":"J Med Genet"},{"issue":"9737","key":"9518_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","volume":"376","author":"A Tutt","year":"2010","unstructured":"Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN et al (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376(9737):235\u2013244. doi: 10.1016\/S0140-6736(10)60892-6","journal-title":"Lancet"},{"issue":"2","key":"9518_CR25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2011.955","volume":"306","author":"A Ziogas","year":"2011","unstructured":"Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C et al (2011) Clinically relevant changes in family history of cancer over time. JAMA 306(2):172\u2013178. doi: 10.1001\/jama.2011.955","journal-title":"JAMA"},{"issue":"3","key":"9518_CR26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejca.2003.09.016","volume":"40","author":"S Malander","year":"2004","unstructured":"Malander S, Ridderheim M, Masback A, Loman N, Kristoffersson U, Olsson H et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422\u2013428. doi: 10.1016\/j.ejca.2003.09.016","journal-title":"Eur J Cancer"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-012-9518-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T15:06:44Z","timestamp":1497971204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-012-9518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9518"],"URL":"https:\/\/doi.org\/10.1007\/s10689-012-9518-6","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,3]]}}}